JP2022536043A5 - - Google Patents

Info

Publication number
JP2022536043A5
JP2022536043A5 JP2021570326A JP2021570326A JP2022536043A5 JP 2022536043 A5 JP2022536043 A5 JP 2022536043A5 JP 2021570326 A JP2021570326 A JP 2021570326A JP 2021570326 A JP2021570326 A JP 2021570326A JP 2022536043 A5 JP2022536043 A5 JP 2022536043A5
Authority
JP
Japan
Application number
JP2021570326A
Other languages
Japanese (ja)
Other versions
JPWO2020243224A5 (https=
JP2022536043A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034794 external-priority patent/WO2020243224A1/en
Publication of JP2022536043A publication Critical patent/JP2022536043A/ja
Publication of JPWO2020243224A5 publication Critical patent/JPWO2020243224A5/ja
Publication of JP2022536043A5 publication Critical patent/JP2022536043A5/ja
Pending legal-status Critical Current

Links

JP2021570326A 2019-05-28 2020-05-28 シトクロムbc1阻害剤とクラリスロマイシン又はアジスロマイシン及びクロファジミンを組み合わせることを特徴とするマイコバクテリア感染症治療用医薬 Pending JP2022536043A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853273P 2019-05-28 2019-05-28
US62/853,273 2019-05-28
PCT/US2020/034794 WO2020243224A1 (en) 2019-05-28 2020-05-28 A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME bc1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN AND CLOFAZIMINE

Publications (3)

Publication Number Publication Date
JP2022536043A JP2022536043A (ja) 2022-08-12
JPWO2020243224A5 JPWO2020243224A5 (https=) 2023-05-31
JP2022536043A5 true JP2022536043A5 (https=) 2023-05-31

Family

ID=73553908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570326A Pending JP2022536043A (ja) 2019-05-28 2020-05-28 シトクロムbc1阻害剤とクラリスロマイシン又はアジスロマイシン及びクロファジミンを組み合わせることを特徴とするマイコバクテリア感染症治療用医薬

Country Status (4)

Country Link
US (1) US20220235047A1 (https=)
EP (1) EP3976031A4 (https=)
JP (1) JP2022536043A (https=)
WO (1) WO2020243224A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI861208B (zh) * 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
TW202237116A (zh) * 2020-12-02 2022-10-01 日商塩野義製藥股份有限公司 以組合細胞色素bc1抑制劑與克拉黴素或阿奇黴素為特徵之用於治療分枝桿菌感染之藥物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA125171C2 (uk) * 2015-07-02 2022-01-26 Янссен Саєнсиз Айрленд Юсі Антибактеріальні сполуки
KR20180053386A (ko) * 2015-09-17 2018-05-21 마빈 제이. 밀러 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물
EP3266454A1 (en) * 2016-07-07 2018-01-10 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Acc inhibitors for use in treating mycobacterial diseases
KR20190121315A (ko) * 2017-03-01 2019-10-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 병용 요법

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)